HIMS Hims & Hers Health PE ratio, current and historical analysis
- Stocks
- Consumer Defensive
- NYSE: HIMS
- PE Ratio
As of Aug 15, 2025, the Hims & Hers Health stock's P/E ratio is 52.9. This results from the current EPS of $0.87 and stock price of $46.02. The PE ratio has increased by 19% from the past four quarters average of 44.5.
HIMS PE ratio history
The PE ratio of Hims & Hers Health has averaged 86.1 over the last two years. The current price-to-earnings ratio of 52.9 is 39% less than the historical average. In the past two years, HIMS's PE ratio reached its highest point in the Jun 2024 quarter at 252.38, when the stock price was $20.19 and the EPS was $0.08. The lowest point was recorded in the Sep 2024 quarter, when it reached 39.19 with a price of $18.42 and an EPS of $0.47.
Hims & Hers Health PE ratio by year
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 41.69 | N/A | $24.18 | $0.58 |
| 2023 | N/A | N/A | $8.9 | -$0.11 |
| 2022 | N/A | N/A | $6.41 | -$0.32 |
| 2021 | N/A | N/A | $6.55 | -$0.58 |
| 2020 | N/A | N/A | $14.6 | -$0.51 |
| 2019 | N/A | N/A | $9.9 | -$2.07 |
Hims & Hers Health PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Jun 2025 | 57.3 | 43.5% | $49.85 | $0.87 |
| Mar 2025 | 39.93 | -4.22% | $29.55 | $0.74 |
| Dec 2024 | 41.69 | 6.38% | $24.18 | $0.58 |
| Sep 2024 | 39.19 | -84.47% | $18.42 | $0.47 |
| Jun 2024 | 252.38 | N/A | $20.19 | $0.08 |
| Mar 2024 | N/A | N/A | $15.47 | -$0.01 |
| Dec 2023 | N/A | N/A | $8.9 | -$0.11 |
| Sep 2023 | N/A | N/A | $6.29 | -$0.17 |
| Jun 2023 | N/A | N/A | $9.4 | -$0.22 |
| Mar 2023 | N/A | N/A | $9.92 | -$0.29 |
| Dec 2022 | N/A | N/A | $6.41 | -$0.32 |
| Sep 2022 | N/A | N/A | $5.58 | -$0.43 |
| Jun 2022 | N/A | N/A | $4.53 | -$0.42 |
| Mar 2022 | N/A | N/A | $5.33 | -$0.37 |
| Dec 2021 | N/A | N/A | $6.55 | -$0.58 |
HIMS Price vs fair value
HIMS average PE ratio chart
The current PE ratio of HIMS is lower than the 3 and 5-year averages.
HIMS PE vs peers
HIMS's PE ratio is above its peer stocks NBIX and NVAX.
| Stock name | PE ratio | Market cap |
|---|---|---|
| NVAX Novavax Inc | 3.68 | $1.56B |
| NBIX Neurocrine Biosciences Inc | 38.19 | $13.18B |
| HIMS Hims & Hers Health Inc | 52.9 | $10.4B |
| NVCR NovoCure Ltd | N/A | $1.31B |
Frequently asked questions
What is Hims & Hers Health's PE ratio?
The price to earnings ratio for HIMS stock as of Aug 15, 2025, stands at 52.9.
What is the 3-year average PE ratio for Hims & Hers Health (HIMS)?
The 3-year average PE ratio for HIMS stock is 86.1.
What is the 5-year average PE ratio for Hims & Hers Health (HIMS)?
The 5-year average PE ratio for HIMS stock is 86.1.
What is the highest PE ratio for HIMS?
The highest quarterly PE ratio in the last two years has been 252.38 and it was in the Jun 2024 quarter.
How does the current PE ratio for HIMS compare to its historical average?
HIMS's price to earnings ratio is currently 39% below its 2-year historical average.
How is HIMS's PE ratio calculated (Hims & Hers Health PE ratio formula)?
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (Aug 15, 2025), Hims & Hers Health's stock price is $46.02. The earnings per share for the trailing twelve months (TTM) ending Jun 2025 is $0.87. Therefore, Hims & Hers Health's price to earnings ratio for today is 52.9. PE RATIO(52.9) = STOCK PRICE($46.02) / TTM EPS($0.87)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.